New EBE president elected
This article was originally published in SRA
Executive Summary
The biotech industry association European Biopharmaceutical Enterprises has elected Marc de Garidel as its new president for a two-year term. Mr de Garidel, vice president south region of Amgen International, takes over the presidency from Genzyme's Dr Carlo Incerti, who will remain on the EBE board as vice president. Mr de Garidel has been on the EBE board since 2006, as vice president and treasurer.
You may also be interested in...
Pharma Guidelines, ending 1 July 2011
Recently updated and newly issued documents
EuropaBio appoints new chairman
EuropaBio, the European biotech industry association, has appointed Stephan Tanda as its new association chair. Mr Tanda, a member of the managing board of life sciences and materials sciences firm DSM, succeeds GlaxoSmithKline's Andrea Rappagliosi, who will remain a member of the EuropaBio board.
Medtech Guidelines, ending 24 June 2011
Recently updated and newly issued documents